Biogen Idec (Nasdaq: BIIB) reports Q3 earnings of $0.60 per share, 11 cents better than estimates. Revenues came in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE